StO2 Performance Measured on Admission to the Emergency Department in the Assessment of Drug Poisoning

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-30

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of the protocol is to evaluate the StO2 performance measured at the admission to the emergency department to identify hemodynamic failure at the admission or within the first three hours of monitoring patients with drug poisoning.

The study hypotheses are:

* The early detection of hypoperfusion by StO2, essential to prevent the development of collapse.
* To limit hemodynamic failure effects, reduce morbidity and mortality of drug poisoning, hospital stay and cost.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Blood Serum Concentrations of Routine Drugs in Patients Treated in the Intensive Care Unit.

NCT02305004

Serum Concentrations Intoxication Post Mortem Concentrations

COMPLETED

Early Detection of At-risk Septic Patients

NCT06253325

Sepsis

RECRUITING

PiCCO ASSESSMENT IN PATIENTS WITH SEPTIC SHOCK

NCT05271032

Septic Shock

COMPLETED

The Effect of Esmolol on Clinical Prognosis of Patients With Severe Sepsis

NCT02794025

Severe Sepsis

COMPLETED NA

Predict Sepsis; the Predictive Value of Bedside Measures in the Ambulance

NCT03249597

Sepsis Sepsis Syndrome Sepsis, Severe

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The procedure is a measurement and non-invasive monitoring system of percentage of oxygen saturation of haemoglobin in tissues using infrared technology. The system used in the study is the tissue oxygenation monitor InSpectraTM StO2 Spot Check, Model 300 consisting of a clamp applied to the base of the thumb of the patient.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drug Poisoning

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Measurement of StO2

The procedure is a measurement and non-invasive monitoring system of percentage of oxygen saturation of haemoglobin in tissues using infrared technology. The system used in the study is the tissue oxygenation monitor InSpectraTM StO2 Spot Check, Model 300 consisting of a clamp applied to the base of the thumb of the patient.

Group Type EXPERIMENTAL

Measurement of StO2

Intervention Type DEVICE

The procedure is a measurement and non-invasive monitoring system of percentage of oxygen saturation of haemoglobin in tissues using infrared technology. The system used in the study is the tissue oxygenation monitor InSpectraTM StO2 Spot Check, Model 300 consisting of a clamp applied to the base of the thumb of the patient.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Measurement of StO2

The procedure is a measurement and non-invasive monitoring system of percentage of oxygen saturation of haemoglobin in tissues using infrared technology. The system used in the study is the tissue oxygenation monitor InSpectraTM StO2 Spot Check, Model 300 consisting of a clamp applied to the base of the thumb of the patient.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* admitted to the emergency department,
* whose pattern of hospitalization is drug poisoning, defined on data from the patient's interrogation or his family if the patient is not able to answer,
* Written informed consent signed by the patient or, if he's unable to sign, by a companion,
* Affiliated to medical insurance

Exclusion Criteria

* Patients without thenar eminence or having a disease of the thenar,
* Refusal to participate in the study,
* Participation in another biomedical research,
* Patient under guardianship, trusteeship or judicial protection,
* Pregnant women or nursing mothers

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No